STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
13
13F, latest reported quarter
What the filings say about MDXH
Insiders, 180 days
+$1,000.0K net bought
1 buyer
Planned sales (Form 144), 90 days
$1.1M
1 notice
Activist stakes (13D), 180 days
1 filing
Largest: 33.2% of the class
MDxHealth insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, MDxHealth SA insiders bought a net $1.0M of stock across 2 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.
1 earlier Form 4 trade (code P or S) here by this insider (1 buy), the last on Feb 3, 2023.
The trade is 31.9% of the 6,903,100 shares held after it.
No other insider bought within 30 days.
13 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director MVM Partners, LLC bought about $1,000.0K of MDXH on Aug 13, 2026, the largest insider purchase at the company since 2023; 13 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 2.2% of the 45,504,584 shares held after it.
No other insider bought within 30 days.
13 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider MVM Partners, LLC bought about $4.0M of MDXH on Feb 3, 2023, the largest insider purchase at the company on our record; 13 funds added in the latest 13F quarter.
2 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
The record shows a net $1.0M bought by insiders over 180 days, 13 funds added last quarter, $1.1M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
MDXH ranks highest on insider conviction (77th percentile) and risk and compliance (64th), and lowest on institutional and government (12th), among Healthcare Services peers.
Insider conviction
77
Inputs
Net Form 4 buying (codes P and S), 180d$1000K · 90 pct, sector of 64
Insider buyers, 180d1 · 63 pct, sector of 64
Institutional and government
12
Inputs
Funds adding, latest quarter13 · 12 pct, sector of 73
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
64
Inputs
Short interest, % of float+2.8% · 64 pct, sector of 93
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Financial health, Growth, US patents
Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MDXH filings, in plain words
Are MDxHealth insiders buying or selling MDXH?
In the 180 days to 2026-10-28, MDxHealth insiders were net buyers, a net $1,000.0K across purchases and sales reported on Form 4, by 1 buyer.
Are there planned insider sales of MDXH?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $1.1M of stock; the latest, by Bleichroeder LP, was filed 2026-09-17.
Read the full summary
In the 180 days to 2026-10-28, MDxHealth insiders were net buyers of MDXH, a net $1,000.0K across purchases and sales reported on Form 4 by 1 buyer. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $1.1M of stock. 1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 33.2% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.
